Thomas O'Neil

Thomas P.
O'Neil worked as Vice President-Finance & Administration at Nodality, Inc. from 2007 to 2009 and at ChemGenex Pharmaceuticals Pty Ltd. from 2009 to 2011.
In 2014, served as Chief Financial Officer & Media Relations Contact at Sorbent Therapeutics, Inc. Held the position of Chief Financial Officer at Arcadia Biosciences, Inc. in 2015.
From 2016 to 2019, was Chief Financial & Accounting Officer at Protagonist Therapeutics, Inc., and from 2019 to 2023, held the same title at Satsuma Pharmaceuticals, Inc. Other roles include Director-Financial Planning & Analysis at Monogram Biosciences, Inc., Vice President-Finance & Administration at HX Diagnostics, Inc., and Principal at Autodesk, Inc., Nellcor, Inc., Miller Freeman, Inc., Covidien LP, and ASM Group, Inc. Education includes undergraduate studies at Pomona College and an MBA from UCLA Anderson School of Management.